🇺🇸 FDA
Patent

US 12377191

Chondroinductive peptides and compositions and methods of use thereof

granted A61KA61K38/00A61K38/08

Quick answer

US patent 12377191 (Chondroinductive peptides and compositions and methods of use thereof) held by The Board of Regents of the University of Oklahoma expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K38/08, A61K47/61, A61K47/65